Showing results (291-300 of 1,193) with videos related to

Sort By:
Pageof 120
The Journal of Antimicrobial Chemotherapy|July 1, 1990
In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patientsK V Rolston, B LeBlanc, D H Ho, et al.
Postgraduate Medicine|October 1, 1987
External expressions of internal malignancyS Dreizen, K B McCredie, G P Bodey, et al.
Anticancer Research|July 1, 1986
Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrateD H Ho, L Townsend, M A Luna, et al.
Medicine|May 1, 1993
Primary Candida pneumonia. Experience at a large cancer center and review of the literatureE Haron, S Vartivarian, E Anaissie, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1981
Disseminated candidiasis caused by four different Candida speciesR L Hopfer, V Fainstein, M P Luna, et al.
The American Journal of Medicine|July 25, 1988
Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patientsP Jones, G P Bodey, K Rolston, et al.
Biomaterials|June 1, 1996
In vitro antimicrobial efficacy of silver iontophoretic catheterI Raad, R Hachem, A Zermeno, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1988
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion testsC C Sanders, J P Iaconis, G P Bodey, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|May 1, 1985
Orofacial aspergillosis in acute leukemiaS Dreizen, G P Bodey, K B McCredie, et al.
Chemotherapy|January 1, 1987
In vitro evaluation of difloxacin (A-56619), A-56620, and other 4-quinolones against isolates from cancer patientsK V Rolston, D H Ho, B LeBlanc, et al.
Pageof 120